Mount Sinai Health System and Holy Name Medical Center Announce Cooperative Partnership
Alliance to focus value-based community care for northern New Jersey
Mount Sinai Health System, an integrated system of eight hospitals, a school of medicine and a continually expanding network of multispecialty services, including more than 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island and Holy Name Medical Center, a comprehensive 361-bed acute care facility providing compassionate and personalized care in Teaneck, NJ, today announced a cooperative partnership to improve access to advanced care, expand clinically aligned services and provide meaningful academic opportunities for physicians and the community while driving down the high cost of care.
Mount Sinai and Holy Name will work to enhance clinical offerings in the local community, sharing research and technological advances while providing cost effective personal care for each patient. Initially, Mount Sinai and Holy Name will focus on coordinating oncology and cardiology service lines focusing on national research initiatives, genetic assessments, physician development and potentially graduate medical education. Both institutions are commencing joint strategic meetings to better understand how this relationship can be valuable for both entities and for their communities.
“We look forward to working with Holy Name’s leadership as we continue to strategically grow Mount Sinai affiliations, “ said Arthur Klein, MD, President of the Mount Sinai Health Network. “Their commitment to excellence and to their community provides a strong foundation for our relationship.”
“Partnering with Mount Sinai to provide enhanced value-based care to patients in their communities will ensure they enjoy long term care improvements,” said Michael Maron, President and Chief Executive Officer, Holy Name Medical Center. “Many hospital collaborations have faltered because of unclear goals. We are different. Holy Name and Mount Sinai share the identical goals and will significantly improve the health outcomes for patients in northern New Jersey as a result.”
About Holy Name Medical Center
Holy Name Medical Center is a fully accredited, not-for-profit healthcare facility based in Teaneck, New Jersey, with off-site locations throughout Bergen County. Founded and sponsored by the Sisters of St. Joseph of Peace in 1925, the comprehensive 361-bed medical center offers leading-edge medical practice and technology administered in an environment rooted in a tradition of compassion and respect for every patient. Holy Name provides high quality health care across a continuum that encompasses education, prevention, early intervention, comprehensive treatment options, rehabilitation and wellness maintenance—from pre-conception through end-of-life.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
Researchers Identify Potential Target for Treatment Among Patients With Type 2 Diabetes
Aug 04, 2022 View All Press Releases
Mount Sinai Researcher Receives Prestigious International Award
Jul 06, 2022 View All Press Releases
